K. Sreter (Zagreb, Croatia), R. Wiewrodt (Münster, Germany), K. Mohorcic (Trzic, Slovenia), L. Kolilekas (Athens, Greece)
Ratio And Regional Distribution Of Genetic Mutation In Lung Cancer In Turkey (REDIGMA)
N. Özçelik (Rize, Turkey), T. Ozlu (Trabzon, Turkey), N. Aksel (Izmir, Turkey), Y. Bulbul (Trabzon, Turkey), Y. Erdogan (Ankara, Turkey), F. Güldaval (Izmir, Turkey), S. Karabulut Gul (Istanbul, Turkey), A. Bircan (Isparta, Turkey), A. Can (Konya, Turkey), N. Oz (Antalya, Turkey), A. Senturk (Ankara, Turkey), S. Arinc (Istanbul, Turkey), T. Kilic (Malatya, Turkey), B. Kurt (Ankara, Turkey), E. Gunay (Afyonkarahisar, Turkey), B. Caglayan (Istanbul, Turkey), D. Celebi Aydin (Balikesir, Turkey), I. Basyigit (Kocaeli, Turkey), I. Savas (Ankara, Turkey), D. Tatar (Izmir, Turkey), S. Aslan (Sivas, Turkey), B. Komurcuoglu (Izmir, Turkey), M. Bayram (Istanbul, Turkey), I. Gulmez (Kayseri, Turkey), O. Dogan (Sivas, Turkey), E. Niksarlioglu (Istanbul, Turkey), E. Kaba (Istanbul, Turkey), E. Aydin Ozgur (Izmir, Turkey)
|   |
Prognosis of uncommon metastasis in non-small-cell lung cancer patients with mutated EGFR
A. Yoshimura (Kyoto, Japan), T. Tsuji (Kyoto, Japan), C. Takumi (Kyoto, Japan), R. Hamashima (Kyoto, Japan), S. Shiotsu (Kyoto, Japan), T. Yuba (Kyoto, Japan), N. Hiraoka (Kyoto, Japan)
| |
Efficacy of Afatinib, Erlotinib, and Gefitinib on epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) patients with brain metastasis: a network meta-analysis
S. Koo (Seoul, Republic of Korea), K. Kim (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), S. Uh (Seoul, Republic of Korea)
| |
Comparison of re-biopsy success rates among procedures and sequential changes of EBUS images
K. Morikawa (Kawasaki, Japan), T. Inoue (Kawasaki, Japan), M. Mineshita (Kawasaki, Japan), T. Miyazawa (Kawasaki, Japan)
| |
Expression status of PD-L1 in NSCLC correlates with disease extension
A. Yamamoto (Amagasaki, Japan), T. Iwata (Amagasaki, Japan)
| |
Expression of PD1, COPD and lung cancer.
F. Verdu Rivera (Palma de Mallorca, Spain), V. Cunill Monjo (Palma de Mallorca, Spain), M. Luna Lopez (Palma de Mallorca, Spain), V. Andreu Matillas (Palma de Mallorca, Spain), A. Iglesias Coma (Palma de Mallorca, Spain), J. Pons De Ves (Palma de Mallorca, Spain), A. Alonso Fernandez (Palma de Mallorca, Spain), F. Garcia-Cosio Piqueras (Palma de Mallorca, Spain), M. Cerda Moncadas (Palma de Mallorca, Spain), J. Sauleda Roig (Palma de Mallorca, Spain)
| |
Retrospective analysis of tumor programmed death-ligand 1 expression in transbronchial biopsy samples
H. Takahashi (Sapporo, Japan), N. Shinagawa (Sapporo, Japan), Y. Hatanaka (Sapporo, Japan), M. Kunisaki (Sapporo, Japan), M. Furuta (Sapporo, Japan), Y. Takashima (Sapporo, Japan), T. Shouji (Sapporo, Japan), H. Kitai (Sapporo, Japan), H. Kikuchi (Sapporo, Japan), H. Mizugaki (Sapporo, Japan), H. Asahina (Sapporo, Japan), E. Kikuchi (Sapporo, Japan), J. Kikuchi (Sapporo, Japan), J. Sakakibara (Sapporo, Japan), Y. Matsuno (Sapporo, Japan), M. Nishimura (Sapporo, Japan)
| |
Benefit of immune checkpoint inhibitors (ICIs) for second-line treatment of advanced non-small cell lung cancer (NSCLC) using restricted mean survival time (RMST).
P. Crequit (Paris, France), A. Vivot (Paris, France), R. Porcher (Paris, France), J. Cadranel (Paris, France)
| |
Hyper-progressive disease in patients with advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo)
A. Costantini (Paris, France), J. Corny (Paris, France), V. Fallet (Paris, France), S. Renet (Paris, France), S. Friard (Suresnes, France), C. Chouaid (Créteil, France), B. Duchemann (Bobigny, France), E. Giroux-Leprieur (Boulogne Billancourt, France), L. Taillade (Paris, France), L. Doucet (Paris, France), M. Nguenang (Paris, France), S. Jouveshomme (Paris, France), M. Wislez (Paris, France), J. Tredaniel (Paris, France), J. Cadranel (Paris, France)
| |
Different Th1 and Th2 citokine profile in serum and tumor microciculation of SCLC and NSCLC patients
V. Karlicic (Belgrade, Republic of Serbia), M. Karlicic (Belgrade, Republic of Serbia), D. Vojvodic (Belgrade, Republic of Serbia)
| |
Pleural and systemic cytokine expression profiles in patients with lung cancer
D. Betz (Munich, Germany), R. Huber (Munich, Germany), D. Kauffmann-Guerrero (Munich, Germany), K. Kahnert (Munich, Germany), S. Kobold (Munich, Germany), P. Mertsch (Munich, Germany), R. Kiefl (Munich, Germany), M. Schaule (Munich, Germany), J. Stump (Munich, Germany), A. Tufman (Munich, Germany)
| |
Radiographic findings after stereotactic radiotherapy for lung carcinoma: retrospective analysis of 90 patients
I. Menoux (Strasbourg, France), D. Antoni (Strasbourg, France), N. Santelmo (Strasbourg, France), P. Truntzer (Strasbourg, France), C. Schumacher (Strasbourg, France), A. Labani (Strasbourg, France), G. NoëL (Strasbourg, France)
| |
How to predict fatal pneumonitis in non-small cell lung cancer (NSCLC) patients treated with radiotherapy (RT)
J. Bordas Martinez (Barcelona, Spain), C. Martin Cabeza (Barcelona, Spain), S. Padrones Sanchez (Barcelona, Spain), R. Palmero Sanchez (Barcelona, Spain), E. Nadal Alforja (Barcelona, Spain), V. Navarro Perez (Barcelona, Spain), J. Dorca Sargatal (Barcelona, Spain), A. Navarro MartíN (Barcelona, Spain), S. Aso Gonzalez (Barcelona, Spain)
| |
Characteristics of radiation pneumonitis and lung function after curatively intended radiotherapy in non-small cell lung carcinoma
J. Berg (Tønsberg, Norway), A. Halvorsen (Oslo, Norway), J. Haugstvedt (Tønsberg, Norway), M. Bengtson (Tønsberg, Norway), O. Brustugun (Oslo, Norway), Å. Helland (Oslo, Norway)
| |
Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis
S. Han (Gyeonggi-do, Republic of Korea), Y. Kim (Gyeonggi-do, Republic of Korea), Y. Lee (Gyeonggi-do, Republic of Korea), J. Park (Gyeonggi-do, Republic of Korea), Y. Cho (Gyeonggi-do, Republic of Korea), H. Yoon (Gyeonggi-do, Republic of Korea), J. Lee (Gyeonggi-do, Republic of Korea), C. Lee (Gyeonggi-do, Republic of Korea), J. Chung (Gyeonggi-do, Republic of Korea), K. Lee (Gyeonggi-do, Republic of Korea), S. Lee (Seoul, Republic of Korea)
| |
Pulmonary tuberculosis and lung cancer: simultaneous and sequential occurrence
B. Kömürcüoglu (Izmir, Turkey), A. Evkan (Izmir, Turkey), G. Polat (Izmir, Turkey), S. Dereli (Izmir, Turkey)
| |
Characterization and management of elderly and very elderly patients with non-small cell lung cancer
V. Clerigo (Lisbon, Portugal), D. Hasmucrai (Lisbon, Portugal), E. Teixeira (Lisbon, Portugal), P. Alves (Lisbon, Portugal), A. Vilariça (Lisbon, Portugal), R. Sotto-Mayor (Lisbon, Portugal)
| |
Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function
Y. Im (Seoul, Republic of Korea), S. Shin (Seoul, Republic of Korea), S. Shin (Seoul, Republic of Korea), H. Gil (Seoul, Republic of Korea), H. Lee (Seoul, Republic of Korea), H. Lee (Seoul, Republic of Korea), J. Kim (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea)
| |
Clinical Features and Treatment Outcome of Carcinomatous Pericarditis due to Lung Cancer.
Y. Kida (Kobe, Japan), Y. Inui (Kobe, Japan), K. Sato (Kobe, Japan), R. Koketsu (Kobe, Japan), T. Sakurai (Kobe, Japan), K. Tada (Kobe, Japan), A. Ikeda (Kobe, Japan), K. Hashimoto (Kobe, Japan), N. Katakami (Kobe, Japan)
| |
Tracheal Chondrosarcoma Masquerading as COPD
D. Terrington (Norwich, United Kingdom), A. Punjabi (Norwich, United Kingdom), A. Bhamani (Cambridge, United Kingdom), A. Kamath (Norwich, United Kingdom)
| |